Syrma Sgs Technology Limited · NSE:SYRMA

Syrma Sgs Technology — Q1 FY24 Earnings Presentation

17 slides from Syrma Sgs Technology's earnings presentation, Aug 1, 2023

  1. Slide 1: Intimation under Regulation 30 SEBI - Investor Presentation

    Date: August 01, 2023 To, Listing Department Department of Corporate Service National Stock Exchange of India Limited BSE Limited Exchange Plaza, C-1, G Block, Bandra Kurla Complex, Phiroze Jeejeebhoy Towers, Bandra (East), Mumbai - 400 051. Dalal Street, Mumbai - 400 001. Symbol: SYRMA Scrip Code:

  2. Slide 2: Syrma SGS Technology Earnings Release Q1 FY24

    Syrma SGS Technology Earnings Release Q1 FY24 August 1st, 2023

  3. Slide 3: Brief Highlights

    Brief Highlights ₹ million • Syrma SGS forays into the lucrative electronic medical devices market through the acquisition of 51% Stake in Johari Digital Healthcare Limited (“JDHL”) for ₹ 2,295 Acquisition million. Additional consideration of up to ₹ 280 million to be paid on achieving certain pre-d

  4. Slide 4: Syrma SGS to Acquire Majority Stake in JDHL – A Medical Devices Company

    Syrma SGS to Acquire Majority Stake in JDHL – A Medical Devices Company STRATEGIC RATIONALE Entry into Medical Devices Foray into Large, fragmented and fast-growing Medical Devices Market segment USFDA / MDSAP compliant facility in India with 18 USFDA 510(k) FDA/MDSAP Approved facility clearances on

  5. Slide 5: Transaction Details

    Transaction Details • Consideration of ₹ 2,295 million to acquire 51% majority stake in Johari Digital Healthcare Limited (“JDHL”) to be paid at the consummation of the transaction. • Additional consideration of up to ₹ 280 million to be paid on achieving certain pre-determined milestones. • Finance

  6. Slide 6: Johari Digital Healthcare Limited (JDHL) Overview

    Johari Digital Healthcare Limited (“JDHL”) Overview • Founded in 1979 & based in Jodhpur, JDHL is a pioneering MedTech company from India, Applying industry insight and technical acumen to accelerate the delivery of smart and affordable healthcare solutions through trusted and deep partnerships with

  7. Slide 7: JDHL Key Products

    JDHL Key Products Box Build Medical Devices Aesthetics Diagnostics Electrical Stimulation / Homogenizer Electro Chemistry Laser / Light Based Electro Chemistry Visualization Equipment Radio Frequency Trusculpt Flex /ID Xeo Fastprep 24 Gazelle Camera Equipment 5G Hemex Health

  8. Slide 8: Syrma SGS Q1 FY24 Performance

    Syrma SGS Q1 FY24 Performance

  9. Slide 9: Brief Financial Summary Q1 FY24

    Brief Financial Summary Q1 FY24 ₹ Million Particulars Q1 FY23 Q4 FY23 Q1 FY24 % Change, YoY Total Revenue 3,918 7,029 6,234 59.1% Gross Profit 1,118 1,693 1,547 38.5% Margin % 28.5% 24.1% 24.8% (3.7%) Operating Expenses 758 885 957 26.4% EBITDA 360 808 590 63.9% Margin % 9.2% 11.5% 9.5% 0.3% Depreci

  10. Slide 10: Financial Highlights: Q1 FY24

    Financial Highlights : Q1 FY24 ₹ Million Revenue EBITDA ₹ 7,029 ₹ 808 ₹ 6,234 ₹ 590 ₹ 360 ₹ 3,918 Q4 FY23 Q1 FY23 Q1 FY24 Q4 FY23 Q1 FY23 Q1 FY24 Profit Before Tax Profit After Tax ₹ 681 ₹ 429 ₹ 413 ₹ 283 ₹ 239 ₹ 172 Q4 FY23 Q1 FY23 Q1 FY24 Q4 FY23 Q1 FY23 Q1 FY24 9

  11. Slide 11: Industry Segments

    Industry Segments Revenue (₹ million) Industry YoY Q1 FY23 Q1 FY24 Auto 832 1,451 74.5% Consumer 786 2,324 195.8% Healthcare 566 157 (72.3%) Industrials 1,192 1,775 48.9% IT and Railways 518 307 (40.8%) Total 3,893 6,013 54.4% 10

  12. Slide 12: Industry Segment: Material Margins

    Industry Segment: Material Margins Material Margin (%) Industry Q1 FY23 Q1 FY24 Auto 17.9% 21.8% Consumer 33.2% 18.1% Healthcare 49.3% 44.1% Industrials 34.5% 29.2% IT and Railways 10.0% 12.5% 11

  13. Slide 13: Debt and Cash

    Debt and Cash ₹ Million Particulars 31-Mar-23 30-Jun-23 Term Loan 899 897 Working Capital Loan 2,570 2,900 Total Debt 3,468 3,797 Investments 8,291 7,702 Cash and Cash Equivalents 544 656 Total Cash & Equivalents 8,836 8,357 Net Debt / (Cash) (5,367) (4,560) 12

  14. Slide 14: Financial Ratios

    Financial Ratios Particulars Q1 FY23 Q1 FY24 EBITDA Margin (%) 9.2% 9.5% PAT Margin (%) 4.4% 4.5% Net Working Capital Days1 73 67 Net Working Capital Days2 86 69 Net Debt to EBITDA 0.8 NM ROCE (%) 13.3% 13.6% ROCE (%)3 16.6% 20.0% Notes: 1. Net Working Capital Days based on the average of opening an

  15. Slide 15: Most Preferred Workplace 2023-2024

    Most Preferred Workplace 2023-2024 Syrma SGS is the first and only Indian EMS company to have received the honor. 7 Recognized among Most Preferred Workplaces based on an industry- wide consumer study conducted by LeadCap Ventures.

  16. Slide 16: Q1 FY24: Awards & Recognitions

    Q1 FY24: Awards & Recognitions 3rd place - Kaizen award from CII Southern Regional – July’23 Runner up – Hand Soldering Skill Competition 2023 by IPC India 7 “Timely Managing the Project Milestones” from Marquart India Pvt Ltd – June’23

  17. Slide 17: Thank you

    Investors Contact: Thank you Nikhil Gupta, CFA +91 - 11 - 4235 1122 investor.relations@syrmasgs.com www.syrmasgs.com

Syrma SGS Technology — Q1 FY24 Earnings Presentation on 6ix